M
10b5-1 Plan
$ Value
$5K
Shares
679
Price
$8
Filed
Apr 3
Insider
Name
Doyle Mittie
Title
Chief Medical Officer
CIK
0001918845
Roles
Officer
Transaction Details
Transaction Date
2026-04-01
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
4,301
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025. | The stock option vests twenty-five percent (25%) on January 28, 2026 and the remainder will vest in equal monthly installments over the following three (3) years, subject to the Reporting Person's continued service on each such vesting date.
Filing Info
Doyle Mittie's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-06 | AVTX | M | $50K |
| 2026-04-06 | AVTX | ▼ | $72K |
| 2026-04-06 | AVTX | M | $0 |
| 2026-04-01 | AVTX | M | $5K |
| 2026-04-01 | AVTX | ▼ | $11K |
| 2026-04-01 | AVTX | M | $0 |
| 2025-08-07 | CGEM | A | $0 |
Other Insiders at AVTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| KAPLAN GILLA | — | — | 2026-03-28 |
|
NEIL GARRY ARTHUR
Chief Executive Officer
|
— | — | 2026-03-28 |
| Lind Kevin Robert | — | — | 2026-03-31 |
| Jain Rita | — | — | 2026-03-31 |
| Chan Mitchell | — | — | 2026-03-28 |
|
Sullivan Christopher Ryan
Chief Financial Officer
|
— | $271K | 2026-04-02 |
| KANTOFF AARON | — | — | 2026-03-28 |
|
Doyle Mittie
Chief Medical Officer
|
— | $82K | 2026-04-06 |
| Goldman Jonathan | — | — | 2026-03-28 |
| Truex Samantha | — | — | 2026-03-28 |